Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

NCT01860144 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT01860144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01860144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
Lead sponsor
Peking University
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2012
Completion date
December 31, 2015
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer